2 active not recruiting, 1 withdrawn. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 2, Withdrawn 1 |
| Phase 1 | 2 | Active not recruiting 2 |
Follow Refractory T Lymphoblastic Lymphoma: new trials by email Literature Review of Refractory T Lymphoblastic Lymphoma trials Research Report on Refractory T Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) AKR1C3-activated Prodrug AST-3424, Biopsy Procedure, Biospecimen Collection - Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | SWOG Cancer Research Network | 67 | 2021-02-08 | 2026-09-01 |
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia Biospecimen Collection, Computed Tomography, Lumbar Puncture - Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 40 | 2018-08-13 | 2026-10-06 |
| Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Asparaginase, Cyclophosphamide, Doxorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Withdrawn | University of Washington | 2018-07-01 | 2018-11-14 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (3) · Burkitt Lymphoma (2) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Lymphoma (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Herpesviridae Infections (2) · Infections (2) · Lymphoma, B-Cell (2)
Specimen Handling (2) · Vincristine (2) · Asparaginase (1) · Biopsy (1) · Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Imatinib Mesylate (1) · Leyk (1) · Magnetic Resonance Spectroscopy (1) · Prednisone (1) · Rituximab (1) · Spinal Puncture (1) · deltacortene (1) · prednylidene (1)
ECOG-ACRIN Cancer Research Group (1) · SWOG Cancer Research Network (1) · University of Washington (1)
United States (3) · Puerto Rico (1)
Anjali S Advani (1) · Neil D Palmisiano (1) · Ryan Cassaday (1)
P30CA015704 (1), U10CA180820 (1), U10CA180888 (1)